ArticleMolecular medicine (Cambridge, Mass.)2019

Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data.

Ali Khosravi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.